ID

31600

Descripción

Phase I Targeting Dominant Intraprostatic Lesion Using MR Spectroscopy and HDR Brachytherapy; ODM derived from: https://clinicaltrials.gov/show/NCT00807820

Link

https://clinicaltrials.gov/show/NCT00807820

Palabras clave

Versiones (1)
  1. 11/9/18 11/9/18 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

11 de septiembre de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Prostate Cancer NCT00807820

Inglés

Eligibility Prostate Cancer NCT00807820

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
patient must be a candidate for hdr prostate brachytherapy
Descripción

Patient Appropriate High dose rate brachytherapy Prostate

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C1548787
UMLS CUI [1,3]
C0454270
UMLS CUI [1,4]
C0033572
patient must be able to have mr scan
Descripción

Ability Receive MRI scan

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0085732
UMLS CUI [1,2]
C1514756
UMLS CUI [1,3]
C0024485
patient must have a visible dil on mrs
Descripción

Lesion of prostate Predominant Visible Magnetic Resonance Spectroscopy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0577255
UMLS CUI [1,2]
C1542147
UMLS CUI [1,3]
C0205379
UMLS CUI [1,4]
C0024487
patient has signed the protocol consent form
Descripción

Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
no prior pelvic or prostate radiation or chemotherapy for any reason
Descripción

Radiotherapy to pelvis Absent | Radiotherapy to prostate Absent | Prior Chemotherapy Absent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1536155
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0948317
UMLS CUI [2,2]
C0332197
UMLS CUI [3,1]
C1514457
UMLS CUI [3,2]
C0332197
induction hormonal therapy beginning ≤ 120 days prior to study entry is acceptable only if there is a mri/mrs done prior to starting hormonal therapy
Descripción

Induction Hormone Therapy | MRI prior to Hormone Therapy | MRS prior to Hormone Therapy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0600558
UMLS CUI [1,2]
C0279025
UMLS CUI [2,1]
C0024485
UMLS CUI [2,2]
C0332152
UMLS CUI [2,3]
C0279025
UMLS CUI [3,1]
C0024487
UMLS CUI [3,2]
C0332152
UMLS CUI [3,3]
C0279025
prostate specific antigen prior to any (hormonal) therapy must be ≤ 20 ng/ml
Descripción

Prostate specific antigen measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201544
one of the following combinations of factors:
Descripción

Combination Factor

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0205195
UMLS CUI [1,2]
C1521761
clinical stage t2a-2b, gleason score 2-6 and psa ≥ 10 but ≤ 20
Descripción

TNM clinical staging | Gleason score | Prostate specific antigen measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3258246
UMLS CUI [2]
C3203027
UMLS CUI [3]
C0201544
clinical stage t3a-t3b, gleason score 2-6 and psa ≤ 20
Descripción

TNM clinical staging | Gleason score | Prostate specific antigen measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3258246
UMLS CUI [2]
C3203027
UMLS CUI [3]
C0201544
clinical stage t2a-t3b, gleason score 7-10 and psa ≤ 20
Descripción

TNM clinical staging | Gleason score | Prostate specific antigen measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3258246
UMLS CUI [2]
C3203027
UMLS CUI [3]
C0201544
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
patient with hip prosthesis
Descripción

Hip prosthesis

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0019560
patient with pacemaker
Descripción

Artificial cardiac pacemaker

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0030163
patient with history of radical surgery for prostate
Descripción

Operation on prostate Radical

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0194790
UMLS CUI [1,2]
C0439807
patient with claustrophobia
Descripción

Claustrophobia

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0008909
patient with metal in body not safe for mr
Descripción

Metal Body | At risk Magnetic Resonance Imaging

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0025552
UMLS CUI [1,2]
C1268086
UMLS CUI [2,1]
C1444641
UMLS CUI [2,2]
C0024485
stage t4 disease
Descripción

Disease TNM clinical staging

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C3258246
lymph node involvement (n1)
Descripción

Lymph Node Involvement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0806692
evidence of distant metastases (m1)
Descripción

Distant metastasis

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1269798
previous hormonal therapy beginning > 120 days prior to registration
Descripción

Prior Hormone Therapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1514460
hormonal therapy prior to mri/mrs
Descripción

Hormone Therapy prior to MRI | Hormone Therapy prior to MRS

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0279025
UMLS CUI [1,2]
C0332152
UMLS CUI [1,3]
C0024485
UMLS CUI [2,1]
C0279025
UMLS CUI [2,2]
C0332152
UMLS CUI [2,3]
C0024487
Volver a la parte superior de la página

Similar models

Eligibility Prostate Cancer NCT00807820

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Patient Appropriate High dose rate brachytherapy Prostate
Item
patient must be a candidate for hdr prostate brachytherapy
boolean
C0030705 (UMLS CUI [1,1])
C1548787 (UMLS CUI [1,2])
C0454270 (UMLS CUI [1,3])
C0033572 (UMLS CUI [1,4])
Ability Receive MRI scan
Item
patient must be able to have mr scan
boolean
C0085732 (UMLS CUI [1,1])
C1514756 (UMLS CUI [1,2])
C0024485 (UMLS CUI [1,3])
Lesion of prostate Predominant Visible Magnetic Resonance Spectroscopy
Item
patient must have a visible dil on mrs
boolean
C0577255 (UMLS CUI [1,1])
C1542147 (UMLS CUI [1,2])
C0205379 (UMLS CUI [1,3])
C0024487 (UMLS CUI [1,4])
Informed Consent
Item
patient has signed the protocol consent form
boolean
C0021430 (UMLS CUI [1])
Radiotherapy to pelvis Absent | Radiotherapy to prostate Absent | Prior Chemotherapy Absent
Item
no prior pelvic or prostate radiation or chemotherapy for any reason
boolean
C1536155 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0948317 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C1514457 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
Induction Hormone Therapy | MRI prior to Hormone Therapy | MRS prior to Hormone Therapy
Item
induction hormonal therapy beginning ≤ 120 days prior to study entry is acceptable only if there is a mri/mrs done prior to starting hormonal therapy
boolean
C0600558 (UMLS CUI [1,1])
C0279025 (UMLS CUI [1,2])
C0024485 (UMLS CUI [2,1])
C0332152 (UMLS CUI [2,2])
C0279025 (UMLS CUI [2,3])
C0024487 (UMLS CUI [3,1])
C0332152 (UMLS CUI [3,2])
C0279025 (UMLS CUI [3,3])
Prostate specific antigen measurement
Item
prostate specific antigen prior to any (hormonal) therapy must be ≤ 20 ng/ml
boolean
C0201544 (UMLS CUI [1])
Combination Factor
Item
one of the following combinations of factors:
boolean
C0205195 (UMLS CUI [1,1])
C1521761 (UMLS CUI [1,2])
TNM clinical staging | Gleason score | Prostate specific antigen measurement
Item
clinical stage t2a-2b, gleason score 2-6 and psa ≥ 10 but ≤ 20
boolean
C3258246 (UMLS CUI [1])
C3203027 (UMLS CUI [2])
C0201544 (UMLS CUI [3])
TNM clinical staging | Gleason score | Prostate specific antigen measurement
Item
clinical stage t3a-t3b, gleason score 2-6 and psa ≤ 20
boolean
C3258246 (UMLS CUI [1])
C3203027 (UMLS CUI [2])
C0201544 (UMLS CUI [3])
TNM clinical staging | Gleason score | Prostate specific antigen measurement
Item
clinical stage t2a-t3b, gleason score 7-10 and psa ≤ 20
boolean
C3258246 (UMLS CUI [1])
C3203027 (UMLS CUI [2])
C0201544 (UMLS CUI [3])
Item Group
C0680251 (UMLS CUI)
Hip prosthesis
Item
patient with hip prosthesis
boolean
C0019560 (UMLS CUI [1])
Artificial cardiac pacemaker
Item
patient with pacemaker
boolean
C0030163 (UMLS CUI [1])
Operation on prostate Radical
Item
patient with history of radical surgery for prostate
boolean
C0194790 (UMLS CUI [1,1])
C0439807 (UMLS CUI [1,2])
Claustrophobia
Item
patient with claustrophobia
boolean
C0008909 (UMLS CUI [1])
Metal Body | At risk Magnetic Resonance Imaging
Item
patient with metal in body not safe for mr
boolean
C0025552 (UMLS CUI [1,1])
C1268086 (UMLS CUI [1,2])
C1444641 (UMLS CUI [2,1])
C0024485 (UMLS CUI [2,2])
Disease TNM clinical staging
Item
stage t4 disease
boolean
C0012634 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
Lymph Node Involvement
Item
lymph node involvement (n1)
boolean
C0806692 (UMLS CUI [1])
Distant metastasis
Item
evidence of distant metastases (m1)
boolean
C1269798 (UMLS CUI [1])
Prior Hormone Therapy
Item
previous hormonal therapy beginning > 120 days prior to registration
boolean
C1514460 (UMLS CUI [1])
Hormone Therapy prior to MRI | Hormone Therapy prior to MRS
Item
hormonal therapy prior to mri/mrs
boolean
C0279025 (UMLS CUI [1,1])
C0332152 (UMLS CUI [1,2])
C0024485 (UMLS CUI [1,3])
C0279025 (UMLS CUI [2,1])
C0332152 (UMLS CUI [2,2])
C0024487 (UMLS CUI [2,3])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial